Ana Oliveira

Ana Oliveira

Auto-generated profile, based on publicly available information

Ana Oliveira

Escola Superior de Tecnologia da Saude de Lisboa, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
LVLuísa Veiga
Luísa Veiga
JSJose Silva-Nunes
Jose Silva-Nunes
AMAlice Melão
Alice Melão
AOAna Oliveira
Ana Oliveira
LDLeone Duarte
Leone Duarte
Miguel BritoMiguel Brito
Miguel Brito
Introduction: Obesity became a major public health problem as a result of its increasing prevalence worldwide. Paraoxonase-1 (PON1) is an esterase able to protect membranes and lipoproteins from oxidative modifications. At the PON1 gene, several polymorphisms in the promoter and coding regions have been identified. The aims of this study were i) to assess PON1 L55M and Q192R polymorphisms as a risk factor for obesity in women; ii) to compare PON1 activity according to the expression of each allele in L55M and Q192R polymorphisms; iii) to compare PON1 activity between obese and normal-weight women.Materials and methods: We studied 75 healthy (35.9±8.2 years) and 81 obese women (34.3±8.2 years). Inclusion criteria for obese subjects were body mass index ≥30 kg/m2 and absence of inflammatory/neoplasic conditions or kidney/hepatic dysfunction. The two PON1 polymorphisms were assessed by real-time PCR with TaqMan probes. PON1 enzymatic activity was assessed by spectrophotometric methods, using paraoxon as a substrate.Results: No significant differences were found for PON1 activity between normal and obese women. Nevertheless, PON1 activity was greater (P<0.01) for the RR genotype (in Q192R polymorphism) and for the LL genotype (in L55M polymorphism). The frequency of allele R of Q192R polymorphism was significantly higher in obese women (P<0.05) and was associated with an increased risk of obesity (odds ratio=2.0 – 95% confidence interval (1.04; 3.87)).Conclusion: L55M and Q192R polymorphisms influence PON1 activity. The allele R of the Q192R polymorphism is associated with an increased risk for development of obesity among Portuguese Caucasian premenopausal women.

1 April 2013 in Obesity Facts
Verified
Journal Article
Open access
PDF file
JSJose Silva-Nunes
Jose Silva-Nunes
AOAna Oliveira
Ana Oliveira
LDLeone Duarte
Leone Duarte
MBMargarida Barradas
Margarida Barradas
AMAlice Melão
Alice Melão
LVLuísa Veiga
Luísa Veiga
Objective: To assess different factors influencing adiponectinemia in obese and normal-weight women; to identify factors associated with the variation (Δ) in adiponectinemia in obese women following a 6-month weight loss program, according to surgical/non-surgical interventions. Methods: We studied 100 normal-weight women and 112 obese premenopausal women; none of them was on any medical treatment. Women were characterized for anthropometrics, daily macronutrient intake, smoking status, contraceptives use, adiponectin as well as IL-6 and TNF-α serum concentrations. Results: Adiponectinemia was lower in obese women (p < 0.001), revealing an inverse association with waist-to-hip ratio (p < 0.001; r = -0.335). Normal-weight women presented lower adiponectinemia among smokers (p = 0.041); body fat, waist-to-hip ratio, TNF-α levels, carbohydrate intake, and smoking all influence adiponectinemia (r2 = 0.436). After weight loss interventions, a significant modification in macronutrient intake occurs followed by anthropometrics decrease (chiefly after bariatric procedures) and adiponectinemia increase (similar after surgical and non-surgical interventions). After bariatric intervention, Δ adiponectinemia was inversely correlated to Δ waist circumference and Δ carbohydrate intake (r2 = 0.706). Conclusion: Anthropometrics, diet, smoking, and TNF-α levels all influence adiponectinemia in normal-weight women, although explaining less than 50% of it. In obese women, anthropometrics modestly explain adiponectinemia. Opposite to non-surgical interventions, after bariatric surgery adiponectinemia increase is largely explained by diet composition and anthropometric changes.

1 April 2013 in Endocrine Abstracts
Verified
Journal Article
Closed access
JSJose Silva-Nunes
Jose Silva-Nunes
ZPZulmira Peeraly
Zulmira Peeraly
NPNuno Pedroso
Nuno Pedroso
AOAna Oliveira
Ana Oliveira
LDLeone Duarte
Leone Duarte
LVLuísa Veiga
Luísa Veiga
Background: Obesity represents a cardiovascular risk factor. Monocyte chemoattractant protein-1 (MCP-1) is a known regulator of monocyte recruitment to sites of inflammation, and participates at the early phases of atherogenesis. Apolipoproteins, as part of the lipoprotein particles, are classically coupled with cardiovascular risk distinction. Aims: To assess the association of anthropometric parameters, insulin resistance and MCP-1 levels with classic lipid and apolipoprotein profile, in both obese and normal-weight premenopausal women. Methods: We studied 72 obese (age=34.6±7.8 years, BMI=44.4±8.5 kg/m2, waist circumference=118.6±15.1 cm) and 73 normal-weight pre-menopausal women (age=33.6±8.4 years, BMI=21.4±1.7 kg/m2, waist circumference=71.5±5.8 cm). Women were characterized for anthropometrics and a fasting blood sample was collected for MCP-1, insulin, glucose, total, LDL and HDL-cholesterol, triglycerides, free fatty acids and apolipoproteins A-I, A-II, B, C-II, C-III and E; insulin resistance was assessed by the homeostatic model assessment (HOMA-IR). We compared biochemical parameters between groups. In each group, we looked for correlations of lipid/apolipoprotein profile with MCP-1, insulin resistance and anthropometrics. Results: Obese women presented significantly higher triglycerides (P<0.001) and MCP-1 levels (P=0.001) and significantly lower levels of HDL-cholesterol (P<0.001) and apolipoprotein A-I (P<0.001); we also found a trend for lower apolipoprotein A-II (P=0.07). In the obese group (but not in the non-obese), MCP-1 was directly correlated with apolipoprotein E (P=0.007; r=0.35) and inversely associated with HDL-cholesterol (P=0.013; r=−0.321) and apolipoprotein A-I (P=0.021; r=−0.3). HOMA-IR was inversely associated with HDL-cholesterol (P=0.032; r=−0.252) and directly associated with triglycerides (P=0.003; r=0.344). MCP-1 was not correlated with anthropometrics or HOMA-IR. Conclusions: The higher levels of MCP-1 and triglycerides and lower levels of HDL-cholesterol/apolipoprotein A-I observed in the obese women are consistent with a higher atherosclerotic activity. The association of MCP-1 levels with apolipoproteins A-I and E in obese women, independently from anthropometrics or insulin resistance, may indicate a way of regulation of the atherosclerotic activity in obesity.